Boston Scientific Corporation

Equities

BSX

US1011371077

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX 01:45:33 2024-03-28 pm EDT 5-day change 1st Jan Change
68.6 USD -0.02% Intraday chart for Boston Scientific Corporation +1.53% +18.66%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Scivita Medical Technology Co., Ltd. and Boston Scientific Corporation Sign an Expanded Strategic Cooperation Arrangement CI
Axonics Wins Shareholder Approval of Merger With Boston Scientific MT
Boston Scientific Insider Sold Shares Worth $963,930, According to a Recent SEC Filing MT
TD Cowen Raises Boston Scientific's Price Target to $77 From $65, Maintains Outperform Rating MT
Transcript : Boston Scientific Corporation Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-06-2024 09:10 AM
Boston Scientific Insider Sold Shares Worth $463,322, According to a Recent SEC Filing MT
Boston Scientific Receives FDA Approval for the AGENT Drug-Coated Balloon MT
US FDA approves Boston Scientific's heart device RE
Boston Scientific Insider Sold Shares Worth $467,093, According to a Recent SEC Filing MT
Boston Scientific Prices $2.17 Billion Euro-Denominated Notes Offering MT
Nvidia and the moon Our Logo
ANALYST RECOMMENDATIONS : Block, Quanta Services, Nvidia, Home Depot, Nutrien... Our Logo
Boston Scientific Insider Sold Shares Worth $455,223, According to a Recent SEC Filing MT
Zimmer Biomet forecasts upbeat 2024 profit on steady medical devices demand RE
Edwards Lifesciences beats quarterly estimates on strong heart device sales RE
GE HealthCare forecasts 2024 profit largely above estimates RE
North American Morning Briefing : Jobs Report Tops -2- DJ
Raymond James Adjusts Price Target on Boston Scientific to $73 From $67, Maintains Strong Buy Rating MT
Jefferies Adjusts Price Target on Boston Scientific to $74 From $62, Maintains Buy Rating MT
JPMorgan Chase Adjusts Price Target on Boston Scientific to $72 From $60, Maintains Overweight Rating MT
Mizuho Securities Upgrades Boston Scientific to Buy From Neutral, Raises Price Target to $80 From $65 MT
Wells Fargo Raises Price Target on Boston Scientific to $72 From $70, Maintains Overweight Rating MT
Truist Securities Raises Price Target on Boston Scientific to $73 From $70, Keeps Buy Rating MT
Canaccord Genuity Adjusts Price Target on Boston Scientific to $81 From $77, Keeps Buy Rating MT
Needham Adjusts Boston Scientific's Price Target to $71 From $60, Keeps Buy Rating MT
Chart Boston Scientific Corporation
More charts
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%); - endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ; - neuromodulation (2%). The United States account for 59.2% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
33
Last Close Price
68.62 USD
Average target price
71.73 USD
Spread / Average Target
+4.54%
Consensus
  1. Stock
  2. Equities
  3. Stock Boston Scientific Corporation - Nyse
  4. News Boston Scientific Corporation
  5. Morgan Stanley Adjusts Price Target on Boston Scientific to $58 From $56, Maintains Overweight Rating